Fill out our short intake form and our clinical team will review your information.

In general, you may qualify if your BMI is 30 or above, or 27 or above with a weight-related health condition.

Medical history, current medications, and other individual factors are also considered.

Most patients begin to notice a reduction in appetite within the first 1–2 weeks. Visible weight loss typically follows within the first month.

Results vary based on starting weight, dosage, and how consistently nutrition and lifestyle habits are followed alongside treatment.

GLP-1 medications are not recommended during pregnancy or breastfeeding.

Not necessarily.

All injections are administered by our clinical staff at your weekly in-office appointment. You don’t need to learn to self-inject — that’s one of the core advantages of our in-clinic model.

If you have experience self-injecting and feel more comfortable doing so, you can self-inject at the privacy of your home by purchasing a monthly supply (vial, available only if prescription is approved)

Muscle loss is a real risk with rapid weight loss on any protocol, but it is largely preventable.

Prioritizing protein intake and incorporating strength training throughout your treatment are the two most effective defenses.

Our team will guide you on both from day one.

Most side effects are mild and temporary. If you experience nausea, constipation, or fatigue, there are practical dietary and lifestyle strategies that help significantly.

Because you visit us weekly, our team can catch and address side effects early — adjusting your dose or providing additional support before they become a barrier to continuing treatment.

This varies by patient and goals. Some patients stay on a maintenance dose long-term; others work toward safely tapering off once weight and health goals are achieved.

We discuss long-term planning with every patient as part of the ongoing treatment relationship.

Many patients notice a reduced tolerance for alcohol while on GLP-1 medications — even small amounts may worsen nausea, reflux, and dehydration.

Limiting or avoiding alcohol is advisable, particularly during the early weeks of treatment or after a dose increase.

Weight regain is possible if no sustainable habits are built during treatment.

This is exactly why we emphasize nutrition and movement from the very beginning — patients who build strong habits during treatment are far better positioned to maintain their results over time, with or without medication.

Your description goes here. Edit or remove this text inline or in the description settings

Only stop or change treatment under medical supervision. Stopping suddenly may lead to weight regain or rising blood sugar.

• History of Medullary Thyroid Carcinoma (MTC) – personal or family history.
• Multiple Endocrine Neoplasia Syndrome Type 2 (MEN 2).
• Pregnancy or planning to become pregnant – discontinue at least 1–2 months before conception.
• Breastfeeding – safety not established.
• Severe gastrointestinal disease, especially gastroparesis.
• History of pancreatitis.
• Severe renal impairment (eGFR < 15).
• Severe liver disease – limited safety data.
• Active eating disorders (e.g., anorexia, bulimia).
• Known hypersensitivity to GLP-1 medications or components.